PubMed Health⌕ Search

PubMed · 7156308

Masked depression--an ambiguous entity.

Abstract

The term 'masked depression' is not accepted in current psychiatric classification for three basic reasons: (1) It is not a unique type of a disease or a syndrome, but a state or a stage which is a part of the depressive syndromes. (2) No special list of symptoms which has enough specificity, reliability and validity can be drawn in order to describe this state. (3) The term 'masked' is vague, and is in contradiction to the basic necessity to describe what is observed in contrast to what is unobservable and masked. However, precise and scientific criteria may be unsuitable for diagnostic purposes in these cases which are quite common; thus an entity which has a deep meaning and begs recognition among general physicians may be ignored. In addition, diagnosis of such depression is very important to allow for suitable and adequate treatment procedures. Diagnostic problems, clarification of the term 'masked' and the procedures of diagnosis are discussed in the article.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

I Modai, A Bleich, G Cygielman. 1982. Masked depression--an ambiguous entity.. https://doi.org/10.1159/000287577

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Psychological morbidity and female urinary incontinence.

Female urinary incontinence is a common yet distressing condition. It affects women of all ages, but is especially common in the elderly. Its prevalence ranges from 15 to 55%, depending on age and population studied. Despite the ubiquity of female urinary incontinence, many incontinent women do not voice their suffering, and urinary incontinence has therefore been dubbed 'the silent epidemic'. The physical impact and social isolation associated with urinary incontinence lead to impairment of quality of life and psychological well-being. It is the aim of this review to discuss the epidemiology and psychological impact of urinary incontinence. The recognition and management of incontinence-related psychological morbidity are also explored.

Depressive Disorder↗

Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings.

Vagus nerve stimulation (VNS) therapy is an effective adjunctive treatment for chronic or recurrent treatment-resistant depression in adults, and for pharmacoresistant epilepsy in adults and adolescents. VNS therapy is administered through an implanted pulse generator that delivers programmed electrical pulses through an implanted lead to the left vagus nerve. Programmable pulse parameters include output current, frequency, pulse width, and ON/OFF times. Within a range of typical values, individual patients respond best to different combinations of parameter settings. The physician must identify the optimum settings for each patient while balancing the goals of maximizing efficacy, minimizing side effects, and preserving battery life. Output current is gradually increased from 0.25 mA to the maximum tolerable level (maximum, 3.5 mA); typical therapeutic settings range from 1.0 to 1.5 mA. Greater output current is associated with increased side effects, including voice alteration, cough, a feeling of throat tightening, and dyspnea. Frequency is typically programmed at 20 Hz in depression and 30 Hz in epilepsy. Pulse width is typically 250 or 500 micros. The recommended initial ON time is 30 s, followed by 5 min OFF; OFF time > ON time is recommended. As with pharmacotherapy, VNS therapy must be adjusted in a gradual, systematic fashion to individualize therapy for each patient.

Depressive Disorder↗